FDA Inspection 1228633 — Myung-Ju Ahn, M.D., Ph.D.
The FDA completed an inspection of Myung-Ju Ahn, M.D., Ph.D. on Jan 26, 2024 in Gangnam. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gangnam (Korea (the Republic of))
Additional Details
Clinical Investigator (CI)